TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents

Chemoresistance of colorectal cancer (CRC) leads to tumor recurrence and metastasis and new strategies are urgently needed to improve the outcomes of conventional chemotherapy. Sirtuin (SIRT) inhibitors prevent tumor cell growth by increasing the levels of acetylated histones and non-histones, as we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hao, Chen, Ya, Jiang, Yuan, Wang, Dongliang, Yan, Jun, Zhou, Zhaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388297/
https://www.ncbi.nlm.nih.gov/pubmed/32742376
http://dx.doi.org/10.3892/etm.2020.8818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388297/
https://www.ncbi.nlm.nih.gov/pubmed/32742376
http://dx.doi.org/10.3892/etm.2020.8818

Ejemplares similares